20
Participants
Start Date
January 9, 2024
Primary Completion Date
June 11, 2024
Study Completion Date
June 11, 2024
Placebo
Maltodextrin
315 mg Alpha-GPC
350 mg of 90% pure alpha-GPC (315 mg)
630 mg Alpha-GPC
700 mg of 90% pure alpha-GPC (630 mg)
Center for Applied Health Sciences, Canfield
NNB Nutrition
UNKNOWN
Lindenwood University
OTHER